«Response Center

Below is an extended Response Center news listing. Click here to return to the Response Center main Biocorporate entry.

BioNews Results for Response Center:
Nanotubes detect tumors and deliver high-potency punch News-Medical.Net: Sep 28 2008 10:52PM Matching: response center
Elderly Patients with Metastatic Colorectal Cancer Can Safely Be Treated with Standard Chemotherapy Regimens Oncology Times: Sep 27 2008 12:33AM Matching: response center
Carbon Nanotubes to Target Cancer Cells While Leaving Healthy Cells Untouched Azonano: Sep 26 2008 11:57PM Matching: response center
CDC awards funds for new pandemic planning approaches Centre For Infectious Disease Research and Policy: Sep 25 2008 10:42PM Matching: response center
PAREXEL Expands Early Phase Drug Development Capabilities With Dedicated Proof Of Concept Solutions Pharmaceutical Online: Sep 26 2008 8:35AM Matching: response center
Flu Vaccine Delivered Into Lungs Triggers Stronger Immune Response Impact Lab: Sep 25 2008 5:38PM Matching: response center
Molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy Nature: Sep 24 2008 2:12PM Matching: response center
Parexel Expands Early Phase Capabilities Contract Pharma: Sep 24 2008 2:42AM Matching: response center
Meek Immune Response Helps AIDS Survival Post Chronicle: Sep 23 2008 8:38AM Matching: response center
Women for Women International Project Selected as Top 25 American Express Members Project EMedia Wire: Sep 23 2008 6:27PM Matching: response center
[Melanoma] Helper T-Cell Responses and Clinical Activity of a Melanoma Vaccine With Multiple Peptides From MAG Journal of Clinical Oncology: Sep 23 2008 3:52AM Matching: response center
Roche Announces Tamiflu Antiviral Flu Medication in Ample Supply for 2008-2009 Flu Season Pharma Live: Sep 23 2008 2:14PM Matching: response center
PAREXEL Expands Early Phase Drug Development Capabilities with Dedicated Proof of Concept Solutions KSLA: Sep 23 2008 11:38AM Matching: response center
Acorda Therapeutics Presents Additional Data from Second Positive Phase 3 Study of Fampridine-SR at World Cong Pharma Live: Sep 22 2008 3:12PM Matching: response center
Bucindolol Significantly Reduces Hospitalization and Death in Heart Failure Patients With Very Favorable Genot KSLA: Sep 22 2008 10:33PM Matching: response center

«Response Center

This page contained an extended Response Center news listing. Click here to return to the Response Center main Biocorporate entry.

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.